| 1 | Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries | 33.0 | 54 | Citations (PDF) |
| 2 | Serum levels of advanced glycation end products negatively correlates with activity of Paraoxonase1 and Lecithin-Cholesterol Acyltransferase in diabetic retinopathy; A cross-sectional case-control study | 1.8 | 0 | Citations (PDF) |
| 3 | Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma Are Correlates of Uncontrolled Hypertension in Patients With Type 2 Diabetes | 5.7 | 0 | Citations (PDF) |
| 4 | Nonalcoholic Fatty Liver Disease as a Potential Risk Factor for Cardiovascular Disease in Patients with Type 2 Diabetes: A Prospective Cohort Study | 3.5 | 5 | Citations (PDF) |
| 5 | Vitamin D in Type 2 Diabetes and Its Correlation With Heat Shock Protein 70, Ferric Reducing Ability of Plasma, Advanced Oxidation Protein Products and Advanced Glycation End Products | 2.4 | 4 | Citations (PDF) |
| 6 | Relationship between advanced glycation end‐products and advanced oxidation protein products in patients with type 2 diabetes with and without albuminuria: A cross‐sectional survey | 1.6 | 3 | Citations (PDF) |
| 7 | Incident type 2 diabetes attributable to suboptimal diet in 184 countries | 33.0 | 144 | Citations (PDF) |
| 8 | Children’s and adolescents’ rising animal-source food intakes in 1990–2018 were impacted by age, region, parental education and urbanicity | 14.6 | 17 | Citations (PDF) |
| 9 | Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study | 3.9 | 18 | Citations (PDF) |
| 10 | The trend of achieving ABC goals in patients with type 2 diabetes between 2010-2014 and 2015–2019 | 1.1 | 5 | Citations (PDF) |
| 11 | Vitamin C supplementation lowers advanced glycation end products (<scp>AGEs</scp>) and malondialdehyde (<scp>MDA</scp>) in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled clinical trial | 3.9 | 7 | Citations (PDF) |
| 12 | The lack of association between different LDL‐C levels and oxidized LDL in patients with type 2 diabetes | 1.0 | 1 | Citations (PDF) |
| 13 | Lipid profile, ox‐LDL, and LCAT activity in patients with endometrial carcinoma and type 2 diabetes: The effect of concurrent disease based on a case–control study | 1.6 | 7 | Citations (PDF) |
| 14 | Sugar-sweetened beverage intakes among adults between 1990 and 2018 in 185 countries | 13.7 | 95 | Citations (PDF) |
| 15 | Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort | 3.1 | 7 | Citations (PDF) |
| 16 | COVID-19 infection mortality risk in Iranian patients with type 2 diabetes, hypertension and obesity | 1.0 | 4 | Citations (PDF) |
| 17 | Global, regional, and national consumption of animal-source foods between 1990 and 2018: findings from the Global Dietary Database | 18.4 | 179 | Citations (PDF) |
| 18 | Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes | 2.0 | 11 | Citations (PDF) |
| 19 | Obesity and Diabetic Complications: A Study from the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (NPPCD-2021) Implications for Action on Multiple Scales | 1.8 | 25 | Citations (PDF) |
| 20 | Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data | 2.9 | 8 | Citations (PDF) |
| 21 | The accuracy of triglyceride-glucose (TyG) index for the screening of metabolic syndrome in adults: A systematic review and meta-analysis | 3.2 | 109 | Citations (PDF) |
| 22 | Global dietary quality in 185 countries from 1990 to 2018 show wide differences by nation, age, education, and urbanicity | 14.6 | 200 | Citations (PDF) |
| 23 | Prevalence of diabetes-associated autoantibodies among patients presenting with type 2 diabetes and related metabolic differences | 1.8 | 8 | Citations (PDF) |
| 24 | Iranian National Clinical Practice Guideline for Exercise in Patients with Diabetes | 1.1 | 4 | Citations (PDF) |
| 25 | LDL/apo B ratio predict coronary heart disease in Type 2 diabetes independent of ASCVD risk score: A case-cohort study | 3.2 | 22 | Citations (PDF) |
| 26 | Type 1 diabetic manifestations in a young man triggered by COVID‐19 | 0.6 | 4 | Citations (PDF) |
| 27 | Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates? | 2.0 | 16 | Citations (PDF) |
| 28 | Effects of a Mediterranean diet on the development of diabetic complications: A longitudinal study from the nationwide diabetes report of the National Program for Prevention and Control of Diabetes (NPPCD 2016-2020) | 2.9 | 43 | Citations (PDF) |
| 29 | Waist-To-Height Ratio Is a More Accurate Tool for Predicting Hypertension Than Waist-To-Hip Circumference and BMI in Patients With Type 2 Diabetes: A Prospective Study | 2.7 | 44 | Citations (PDF) |
| 30 | Association between visit-to-visit variability of glycemic indices and lipid profile and the incidence of coronary heart disease in adults with type 2 diabetes | 1.3 | 2 | Citations (PDF) |
| 31 | Correlates of Recurrence-Free Survival in Papillary Thyroid Carcinoma: A Cohort Study in an Iranian Population | 0.1 | 1 | Citations (PDF) |
| 32 | Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran | 1.8 | 27 | Citations (PDF) |
| 33 | Effects of zinc, vitamin D, and their co-supplementation on mood, serum cortisol, and brain-derived neurotrophic factor in patients with obesity and mild to moderate depressive symptoms: A phase II, 12-wk, 2 × 2 factorial design, double-blind, randomized, placebo-controlled trial | 2.7 | 38 | Citations (PDF) |
| 34 | Determinants of glycemic control: Phase 2 analysis from nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2018) | 1.8 | 25 | Citations (PDF) |
| 35 | Serum HSP70 level in patients with endometrial cancer with and without diabetes | 1.8 | 6 | Citations (PDF) |
| 36 | Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes | 4.5 | 40 | Citations (PDF) |
| 37 | Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 | 62.3 | 14,885 | Citations (PDF) |
| 38 | Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 | 62.3 | 7,491 | Citations (PDF) |
| 39 | DPP4 Inhibitors in the Management of Hospitalized Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials | 3.3 | 7 | Citations (PDF) |
| 40 | Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 | 13.4 | 34 | Citations (PDF) |
| 41 | Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 | 62.3 | 512 | Citations (PDF) |
| 42 | The urgent need for integrated science to fight COVID-19 pandemic and beyond | 6.4 | 142 | Citations (PDF) |
| 43 | Nitric oxide and TNF-α are correlates of diabetic retinopathy independent of hs-CRP and HbA1c | 2.5 | 39 | Citations (PDF) |
| 44 | Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017 | 62.3 | 107 | Citations (PDF) |
| 45 | Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study | 3.2 | 39 | Citations (PDF) |
| 46 | Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: A protocol for a case–control pharmacokinetic study | 1.6 | 11 | Citations (PDF) |
| 47 | Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017 | 18.1 | 395 | Citations (PDF) |
| 48 | Inadequate achievement of ABC goals (HbA1c, blood pressure, LDL-C) among patients with type 2 diabetes in an Iranian population, 2012–2017 | 3.0 | 6 | Citations (PDF) |
| 49 | Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 5,099 | Citations (PDF) |
| 50 | Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition | 5.9 | 745 | Citations (PDF) |
| 51 | Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study | 1.8 | 34 | Citations (PDF) |
| 52 | Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 | 33.0 | 71 | Citations (PDF) |
| 53 | Barriers to initiation of insulin therapy in poorly controlled type 2 diabetes based on self-determination theory | 1.0 | 7 | Citations (PDF) |
| 54 | The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 22.9 | 347 | Citations (PDF) |
| 55 | Patient and physician preferences for type 2 diabetes medications: a systematic review | 1.3 | 35 | Citations (PDF) |
| 56 | Role of type 2 diabetes and hemodialysis in serum adipolin concentrations: A preliminary study | 1.1 | 6 | Citations (PDF) |
| 57 | The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 22.9 | 539 | Citations (PDF) |
| 58 | Insulin pen use and diabetes treatment goals: A study from Iran STEPS 2016 survey | 2.3 | 17 | Citations (PDF) |
| 59 | The effects of a <i>Melissa officinalis</i> L. based product on metabolic parameters in patients with type 2 diabetes mellitus: A randomized double-blinded controlled clinical trial | 1.2 | 49 | Citations (PDF) |
| 60 | Inflammatory, oxidative stress and anti-oxidative markers in patients with endometrial carcinoma and diabetes | 3.5 | 59 | Citations (PDF) |
| 61 | Comparison of primary versus secondary prevention of cardiovascular disease in patients with type2 diabetes: Focus on achievement of ABC goals | 3.0 | 7 | Citations (PDF) |
| 62 | Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes | 1.8 | 31 | Citations (PDF) |
| 63 | Associations of Serum S100B and S100P With the Presence and Classification of Diabetic Peripheral Neuropathy in Adults With Type 2 Diabetes: A Case-Cohort Study | 1.8 | 25 | Citations (PDF) |
| 64 | Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 17.9 | 4,081 | Citations (PDF) |
| 65 | Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 4,560 | Citations (PDF) |
| 66 | Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 17.9 | 1,625 | Citations (PDF) |
| 67 | Definition of an oxidative stress status by combined assessment of Malondialdehyde and Oxidized-LDL: A study in patients with type2 diabetes and control | 0.7 | 5 | Citations (PDF) |
| 68 | Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review | 1.1 | 35 | Citations (PDF) |
| 69 | Beneficial Effects of Pentoxifylline Plus Losartan Dual Therapy in Type 2 Diabetes with Nephropathy | 0.9 | 14 | Citations (PDF) |
| 70 | Pulse pressure and diabetes treatments | 1.2 | 9 | Citations (PDF) |
| 71 | Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria | 3.0 | 28 | Citations (PDF) |
| 72 | Diabetes Care in Iran: Where We Stand and Where We Are Headed | 2.2 | 73 | Citations (PDF) |
| 73 | Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 911 | Citations (PDF) |
| 74 | Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 6,542 | Citations (PDF) |
| 75 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 4,187 | Citations (PDF) |
| 76 | Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 386 | Citations (PDF) |
| 77 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 11,367 | Citations (PDF) |
| 78 | Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 428 | Citations (PDF) |
| 79 | Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.3 | 2,721 | Citations (PDF) |
| 80 | Ambulatory blood pressure monitoring and diabetes complications | 1.2 | 33 | Citations (PDF) |
| 81 | Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 | 62.3 | 835 | Citations (PDF) |
| 82 | Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.3 | 2,778 | Citations (PDF) |
| 83 | Global Mortality From Firearms, 1990-2016 | 16.6 | 260 | Citations (PDF) |
| 84 | Association of extracellular heat shock protein 70 and insulin resistance in type 2 diabetes; independent of obesity and C-reactive protein | 2.6 | 20 | Citations (PDF) |
| 85 | National Prevalence of Self-Reported Coronary Heart Disease and Chronic
Stable Angina Pectoris: Factor Analysis of the Underlying Cardiometabolic
Risk Factors in the SuRFNCD-2011 | 2.5 | 19 | Citations (PDF) |
| 86 | Depressive symptoms among metabolically healthy and unhealthy overweight/obese individuals: a comparative study | 0.4 | 6 | Citations (PDF) |
| 87 | GABRIC Diabetes School: an innovative education centre for people with diabetes | 1.0 | 2 | Citations (PDF) |
| 88 | Prevalence of metabolic syndrome in Iran: A 2011 update | 3.0 | 35 | Citations (PDF) |
| 89 | Association of peripheral nesfatin-1 with early stage diabetic nephropathy | 2.3 | 15 | Citations (PDF) |
| 90 | The Prevalence of Metabolic Syndrome and Different Obesity Phenotype in Iranian Male Military Personnel | 1.8 | 23 | Citations (PDF) |
| 91 | Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 | 2.3 | 3,307 | Citations (PDF) |
| 92 | Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 | 62.3 | 626 | Citations (PDF) |
| 93 | Non–high-density lipoprotein fractions are strongly associated with the presence of metabolic syndrome independent of obesity and diabetes: a population-based study among Iranian adults | 1.3 | 18 | Citations (PDF) |
| 94 | Health Effects of Overweight and Obesity in 195 Countries over 25 Years | 34.6 | 6,631 | Citations (PDF) |
| 95 | Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016) | 3.4 | 243 | Citations (PDF) |
| 96 | Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.3 | 669 | Citations (PDF) |
| 97 | Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.3 | 1,828 | Citations (PDF) |
| 98 | Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.3 | 4,202 | Citations (PDF) |
| 99 | Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.3 | 6,881 | Citations (PDF) |
| 100 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.3 | 2,151 | Citations (PDF) |
| 101 | Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 | 62.3 | 316 | Citations (PDF) |
| 102 | Metabolic Syndrome Patients Have Lower Levels of Adropin When Compared With Healthy Overweight/Obese and Lean Subjects | 1.8 | 58 | Citations (PDF) |
| 103 | Cardiovascular risk assessment by FRS and SCORE in Iranian adult population | 1.3 | 14 | Citations (PDF) |
| 104 | Prediction Of Relapse From Hyperthyroidism Following Antithyroid Medication Withdrawal Using Technetium Thyroid Uptake Scanning | 3.3 | 3 | Citations (PDF) |
| 105 | Conflicting interactions of apolipoprotein A and high density lipoprotein cholesterol with microvascular complications of type 2 diabetes | 5.9 | 15 | Citations (PDF) |
| 106 | Depression Improvement Among Patients with HIV and Endocrine Dysfunction After hormone Therapy | 0.0 | 0 | Citations (PDF) |
| 107 | Comment on Fischer et al. Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial. Diabetes Care 2016;39:1364–1370 | 6.2 | 7 | Citations (PDF) |
| 108 | Nonlinear relation between pulse pressure and coronary heart disease in patients with type 2 diabetes or hypertension | 2.2 | 15 | Citations (PDF) |
| 109 | Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study | 2.9 | 7 | Citations (PDF) |
| 110 | Comment on Sharif et al. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care 2016;39:1424–1430 | 6.2 | 2 | Citations (PDF) |
| 111 | Absence of a positive correlation between CRP and leptin in rheumatoid arthritis | 3.3 | 9 | Citations (PDF) |
| 112 | Changing correlations among ADMA, NO and hs-CRP in normoalbuminuric and microalbuminuric patients with type 2 diabetes | 0.7 | 2 | Citations (PDF) |
| 113 | Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.3 | 948 | Citations (PDF) |
| 114 | Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.3 | 1,855 | Citations (PDF) |
| 115 | Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.3 | 5,658 | Citations (PDF) |
| 116 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.3 | 4,711 | Citations (PDF) |
| 117 | Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.3 | 663 | Citations (PDF) |
| 118 | Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 | 62.3 | 483 | Citations (PDF) |
| 119 | Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 13.4 | 181 | Citations (PDF) |
| 120 | Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes | 1.5 | 27 | Citations (PDF) |
| 121 | Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 | 7.9 | 501 | Citations (PDF) |
| 122 | Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients | 0.3 | 22 | Citations (PDF) |
| 123 | Type 2 Diabetes: Model of Factors Associated with Glycemic Control | 1.8 | 35 | Citations (PDF) |
| 124 | Contribution of vitamin D deficiency to the risk of coronary heart disease in subjects with essential hypertension | 1.5 | 21 | Citations (PDF) |
| 125 | Non-linear contribution of serum vitamin D to symptomatic diabetic neuropathy: A case-control study | 5.9 | 24 | Citations (PDF) |
| 126 | Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL): | 0.4 | 15 | Citations (PDF) |
| 127 | Complementary and Alternative Medicine for the Treatment of Obesity: A Critical Review | 1.1 | 78 | Citations (PDF) |
| 128 | Association Of Peripheral 5-Hydroxyindole-3-Acetic Acid, A Serotonin Derivative, with Metabolic Syndrome and Low-Grade Inflammation | 3.3 | 23 | Citations (PDF) |
| 129 | Abdominal obesity and gestational diabetes: the interactive role of magnesium | 0.8 | 15 | Citations (PDF) |
| 130 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.3 | 5,568 | Citations (PDF) |
| 131 | The Global Burden of Cancer 2013 | 14.4 | 2,477 | Citations (PDF) |
| 132 | Revising the fasting glucose threshold for detection of cardiovascular risk factors: analysing two representative population-based studies of more than 50 000 Iranians in 3 years: The National Survey of Risk Factors for Non-Communicable Diseases of Iran | 1.2 | 3 | Citations (PDF) |
| 133 | Associations of small dense low-density lipoprotein and adiponectin with complications of type 2 diabetes | 2.6 | 4 | Citations (PDF) |
| 134 | Authors’ reply | 2.1 | 0 | Citations (PDF) |
| 135 | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes | 1.5 | 24 | Citations (PDF) |
| 136 | An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects | 1.7 | 44 | Citations (PDF) |
| 137 | Pulse pressure does not predict the response of diabetic nephropathy to glucose-lowering therapy | 2.7 | 1 | Citations (PDF) |
| 138 | Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case–control study | 9.1 | 29 | Citations (PDF) |
| 139 | Assessment of serum 25-hydroxy vitamin D improves coronary heart disease risk stratification in patients with type 2 diabetes | 2.9 | 37 | Citations (PDF) |
| 140 | Folate therapy improves the stress-to-rest mean LV volume ratio in myocardial perfusion imaging in patients with diabetes | 2.0 | 0 | Citations (PDF) |
| 141 | Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial | 3.0 | 25 | Citations (PDF) |
| 142 | Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition | 62.3 | 1,727 | Citations (PDF) |
| 143 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.3 | 2,433 | Citations (PDF) |
| 144 | The lost correlation between heat shock protein 70 (HSPA1A) and plasminogen activator inhibitor-1 in patients with type 2 diabetes and albuminuria | 2.6 | 5 | Citations (PDF) |
| 145 | Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes | 0.0 | 4 | Citations (PDF) |
| 146 | Relationship Between Neuropathy with Pressure on Foot in Diabetic Patients | 0.5 | 0 | Citations (PDF) |
| 147 | Association of Vaspin with Metabolic Syndrome: The Pivotal Role of Insulin Resistance | 6.1 | 30 | Citations (PDF) |
| 148 | Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status | 1.3 | 27 | Citations (PDF) |
| 149 | Serum Uric Acid, the Metabolic Syndrome, and the Risk of Chronic Kidney Disease in Patients with Type 2 Diabetes | 1.9 | 23 | Citations (PDF) |
| 150 | Manual or Automated Sphygmomanometer? A Historical Cohort to Quantify Measurement Bias in Blood Pressure Recording | 2.0 | 7 | Citations (PDF) |
| 151 | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.3 | 834 | Citations (PDF) |
| 152 | The Degree of Resistance of Erythrocyte Membrane Cytoskeletal Proteins to Supra-Physiologic Concentrations of Calcium: An In Vitro Study | 2.5 | 5 | Citations (PDF) |
| 153 | Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves’ disease | 2.5 | 9 | Citations (PDF) |
| 154 | The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus | 1.3 | 34 | Citations (PDF) |
| 155 | Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011 | 5.9 | 215 | Citations (PDF) |
| 156 | Homocysteine and metabolic syndrome: From clustering to additional utility in prediction of coronary heart disease | 2.1 | 39 | Citations (PDF) |
| 157 | Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.3 | 1,354 | Citations (PDF) |
| 158 | Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study | 3.1 | 14 | Citations (PDF) |
| 159 | Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes | 2.7 | 22 | Citations (PDF) |
| 160 | Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.3 | 10,022 | Citations (PDF) |
| 161 | The Role of Metabolic Syndrome and Related
Clinical Variables in Determining CEA Levels | 1.7 | 10 | Citations (PDF) |
| 162 | CA 19-9 is Associated with Poor Glycemic Control in Diabetic Patients: Role of Insulin Resistance | 0.4 | 21 | Citations (PDF) |
| 163 | Prostaglandin F2 Alpha Plasma Concentration Predicts Glycemic Control and Oxidation Status in Patients with Type 2 Diabetes Mellitus | 0.4 | 9 | Citations (PDF) |
| 164 | Inconsistency in albuminuria predictors in type 2 diabetes: a comparison between neural network and conditional logistic regression | 4.0 | 17 | Citations (PDF) |
| 165 | Diabetes induces gender gap on LCAT levels and activity | 4.5 | 16 | Citations (PDF) |
| 166 | Treatment with pioglitazone is associated with decreased preprandial ghrelin levels: A randomized clinical trial | 2.8 | 7 | Citations (PDF) |
| 167 | Comparative effects of pioglitazone and metformin on oxidative stress markers in newly diagnosed type 2 diabetes patients: A randomized clinical trial | 2.4 | 46 | Citations (PDF) |
| 168 | Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial | 1.5 | 25 | Citations (PDF) |
| 169 | Appearance of leptin–HSP70 correlation, in type 2 diabetes | 0.7 | 22 | Citations (PDF) |
| 170 | Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: A randomized clinical trial | 5.3 | 191 | Citations (PDF) |
| 171 | Heat shock protein 70 and albuminuria in patients with type 2 diabetes: a matched case control study | 2.6 | 25 | Citations (PDF) |
| 172 | Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: a randomized clinical trial | 0.8 | 54 | Citations (PDF) |
| 173 | The Inverse Relation of CA-125 to Diabetes, Metabolic Syndrome, and Associated Clinical Variables | 1.9 | 6 | Citations (PDF) |
| 174 | Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population | 2.2 | 123 | Citations (PDF) |
| 175 | Accuracy of Anthropometric Parameters in Identification of High-risk Patients Predicted With Cardiovascular Risk Models | 0.9 | 10 | Citations (PDF) |
| 176 | The lost correlation between leptin and CRP in type 2 diabetes | 1.1 | 9 | Citations (PDF) |
| 177 | Association of Depression and Anxiety With Diabetes Mellitus Type 2 Concerning Some Sociological Factors | 0.0 | 46 | Citations (PDF) |
| 178 | Gender-specific changes in physical activity pattern in Iran: national surveillance of risk factors of non-communicable diseases (2007–2011) | 1.8 | 62 | Citations (PDF) |
| 179 | Clinical Lipid Control Success Rate Before and After Percutaneous Coronary Intervention in Iran; a Single Center Study | 0.0 | 4 | Citations (PDF) |
| 180 | Gender Difference in Albuminuria and Ischemic Heart Disease in Type 2 Diabetes | 1.1 | 17 | Citations (PDF) |
| 181 | Apolipoproteins A-I and B As Components of Metabolic Syndrome with Respect to Diabetes Status: A Factor Analysis | 1.9 | 0 | Citations (PDF) |
| 182 | The dual behavior of heat shock protein 70 and asymmetric dimethylarginine in relation to serum CRP levels in type 2 diabetes | 2.3 | 29 | Citations (PDF) |
| 183 | Appropriate BMI cut-off values for identification of metabolic risk factors: Third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007) | 1.2 | 10 | Citations (PDF) |
| 184 | Comparing Abilities of Different Lipid Measures in Diagnosis of Insulin Resistance: A Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) Study | 1.9 | 3 | Citations (PDF) |
| 185 | The Value of Visfatin in the Prediction of Metabolic Syndrome: A Multi-Factorial Analysis | 2.1 | 19 | Citations (PDF) |
| 186 | Amygdalin inhibits angiogenesis in the cultured endothelial cells of diabetic rats | 0.2 | 18 | Citations (PDF) |
| 187 | Insulin Resistance Is Independently Associated with Liver Aminotransferases in Diabetic Patients Without Ultrasound Signs of Nonalcoholic Fatty Liver Disease | 1.9 | 25 | Citations (PDF) |
| 188 | Association of plasma leptin levels and insulin resistance in diabetic women: a cross-sectional analysis in an Iranian population with different results in men and women | 1.8 | 13 | Citations (PDF) |
| 189 | Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes | 4.0 | 21 | Citations (PDF) |
| 190 | Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity | 5.9 | 48 | Citations (PDF) |
| 191 | Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes | 1.1 | 8 | Citations (PDF) |
| 192 | Oxidized Low-Density Lipoprotein Is Negatively Correlated With Lecithin-Cholesterol Acyltransferase Activity in Type 2 Diabetes Mellitus | 0.9 | 24 | Citations (PDF) |
| 193 | Contribution of Serum Leptin to Metabolic Syndrome in Obese and Nonobese Subjects | 2.5 | 32 | Citations (PDF) |
| 194 | Leptin cut-off values for determination of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007) | 2.5 | 14 | Citations (PDF) |
| 195 | Serum Lipoprotein(a) Levels are Greater in Female than Male Patients with Type‐2 Diabetes | 1.3 | 15 | Citations (PDF) |
| 196 | Epidemiology and risk factors of the cardiometabolic syndrome in the Middle East | 1.8 | 13 | Citations (PDF) |
| 197 | Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients | 6.2 | 14 | Citations (PDF) |
| 198 | Vascular endothelial growth factor (VEGF) +405 C/G polymorphism is associated with essential hypertension in a population from Tehran of Iran | 2.5 | 18 | Citations (PDF) |
| 199 | The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus | 2.5 | 17 | Citations (PDF) |
| 200 | Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes | 2.5 | 35 | Citations (PDF) |
| 201 | Graves’ disease and gene polymorphism of TNF-α, IL-2, IL-6, IL-12, and IFN-γ | 2.5 | 33 | Citations (PDF) |
| 202 | Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis | 2.5 | 13 | Citations (PDF) |
| 203 | Disturbances of parathyroid hormone–vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study | 4.2 | 70 | Citations (PDF) |
| 204 | Increased serum HSP70 levels are associated with the duration of diabetes | 2.6 | 115 | Citations (PDF) |
| 205 | Serum Oxidized‐LDL is Associated with Diabetes Duration Independent of Maintaining Optimized Levels of LDL‐Cholesterol | 1.3 | 70 | Citations (PDF) |
| 206 | Physical activity is correlated with serum leptin independent of obesity: results of the national surveillance of risk factors of noncommunicable diseases in Iran (SuRFNCD-2007) | 9.1 | 16 | Citations (PDF) |
| 207 | Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population | 3.5 | 33 | Citations (PDF) |
| 208 | Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007) | 3.7 | 172 | Citations (PDF) |
| 209 | Secular Trends of Obesity in Iran Between 1999 and 2007: National Surveys of Risk Factors of Non-Communicable Diseases | 1.9 | 72 | Citations (PDF) |
| 210 | Insulin Resistance and Breast Carcinogenesis: A Cross-Sectional Study Among Iranian Women with Breast Mass | 1.9 | 5 | Citations (PDF) |
| 211 | Pattern of tobacco use among the Iranian adult population: results of the national Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) | 3.6 | 156 | Citations (PDF) |
| 212 | Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound | 3.5 | 31 | Citations (PDF) |
| 213 | Menopause is an independent predictor of metabolic syndrome in Iranian women | 2.9 | 164 | Citations (PDF) |
| 214 | Genetic susceptibility to Graves’ ophthalmopathy: The role of polymorphisms in anti-inflammatory cytokine genes | 1.2 | 16 | Citations (PDF) |
| 215 | The relationship between ACE gene insertion/deletion polymorphism and diabetic retinopathy in Iranian patients with type 2 diabetes | 1.2 | 21 | Citations (PDF) |
| 216 | Serum heat shock protein 70 and oxidized LDL in patients with type 2 diabetes: does sex matter? | 2.6 | 28 | Citations (PDF) |
| 217 | Graves' ophthalmopathy and gene polymorphisms in interleukin‐1α, interleukin‐1β, interleukin‐1 receptor and interleukin‐1 receptor antagonist | 2.9 | 31 | Citations (PDF) |
| 218 | Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia | 3.1 | 272 | Citations (PDF) |
| 219 | Short term effects of spironolactone on blood lipid profile: a 3‐month study on a cohort of young women with hirsutism | 2.6 | 16 | Citations (PDF) |
| 220 | Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients | 2.7 | 25 | Citations (PDF) |
| 221 | Association between physical activity and insulin resistance in Iranian adults: National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) | 2.8 | 30 | Citations (PDF) |
| 222 | Association between physical activity and metabolic syndrome in Iranian adults: national surveillance of risk factors of noncommunicable diseases (SuRFNCD-2007) | 9.1 | 32 | Citations (PDF) |
| 223 | Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study | 4.0 | 12 | Citations (PDF) |
| 224 | Association of Serum Leptin Levels With Homeostasis Model Assessment–Estimated Insulin Resistance and Metabolic Syndrome: The Key Role of Central Obesity | 1.9 | 53 | Citations (PDF) |
| 225 | Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: The implication of metabolic syndrome to detect insulin resistance | 5.9 | 66 | Citations (PDF) |
| 226 | Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves’ disease | 2.8 | 20 | Citations (PDF) |
| 227 | Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes | 2.3 | 17 | Citations (PDF) |
| 228 | Association of macroalbuminuria with oxidized LDL and TGF-β in type 2 diabetic patients: a case–control study | 1.4 | 10 | Citations (PDF) |
| 229 | Metabolic Syndrome and Insulin Resistance Significantly Correlate with Body Mass Index | 2.5 | 49 | Citations (PDF) |
| 230 | Albuminuria and its correlates in an Iranian type 2 diabetic population | 3.8 | 6 | Citations (PDF) |
| 231 | HbA1c negatively correlates with LCAT activity in type 2 diabetes | 5.9 | 29 | Citations (PDF) |
| 232 | Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults | 5.9 | 77 | Citations (PDF) |
| 233 | Prevalence, Awareness, Treatment, and Risk Factors Associated With Hypertension in the Iranian Population: The National Survey of Risk Factors for Noncommunicable Diseases of Iran | 2.0 | 130 | Citations (PDF) |
| 234 | Prevalence of Diabetes and Impaired Fasting Glucose in the Adult Population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran | 6.2 | 302 | Citations (PDF) |
| 235 | HOMA-Estimated Insulin Resistance Is Associated with Hypertension in Iranian Diabetic and Non-Diabetic Subjects | 3.1 | 14 | Citations (PDF) |
| 236 | Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves’ ophthalmopathy | 1.6 | 14 | Citations (PDF) |
| 237 | The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes | 0.8 | 24 | Citations (PDF) |
| 238 | Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition | 0.8 | 13 | Citations (PDF) |
| 239 | The association between urodynamic findings and microvascular complications in patients with long-term type 2 diabetes but without voiding symptoms | 5.9 | 24 | Citations (PDF) |
| 240 | Title is missing! | 9.4 | 68 | Citations (PDF) |
| 241 | Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review | 2.2 | 1 | Citations (PDF) |
| 242 | Lipid Accumulation Product Index as a Marker of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis | 2.4 | 2 | Citations (PDF) |
| 243 | Association Between Serum Vitamin D and Albuminuria in Type 2 Diabetes Independent of Inflammatory Markers and Renal Function | 2.4 | 0 | Citations (PDF) |
| 244 | Trends of metabolic syndrome among Iranian patients with diabetes and its association with cardiovascular disease and diabetes complications: a nationwide study of the National Program for Prevention and Control of Diabetes | 2.9 | 0 | Citations (PDF) |
| 245 | Low Ankle‐Brachial Index Is Associated With Albuminuria and Diabetic Kidney Disease in Type 2 Diabetes; A Cross Sectional Study | 2.4 | 0 | Citations (PDF) |
| 246 | Glycogenic Hepatopathy: A Case Report of an Underdiagnosed Complication of Poorly Controlled Diabetes Mellitus | 0.6 | 0 | Citations (PDF) |
